Lactobacillus reuteri for Infants with Colic: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Journal of Pediatrics

Volumn 191, Issue , 2017, Pages 170-178.e2

  Fatheree, Nicole Y ^a   Liu, Yuying ^a   Taylor, Christopher M ^b   Hoang, Thomas K ^a   Cai, Chunyan ^a   Rahbar, Mohammad H ^a,c   Hessabi, Manouchehr ^a   Ferris, Michael ^b   McMurtry, Valarie ^b   Wong, Christine ^d   Vu, Ta ^d   Dancsak, Theresa ^d   Wang, Ting ^a   Gleason, Wallace ^a   Bandla, Vinay ^a   Navarro, Fernando ^a   Tran, Dat Q ^a   Rhoads, J Marc ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d MEMORIAL HERMANN HOSPITAL   (United States)

Author keywords

Barr diary; crying; immunology; infant; microbiome; neutropenia; regulatory T cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; BICARBONATE; C REACTIVE PROTEIN; CALCIUM; CALGRANULIN; CREATININE; ELECTROLYTE; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; LANSOPRAZOLE; NITROGEN; OSTEOPROTEGERIN; PLACEBO; PROBIOTIC AGENT; PROTEIN; RANITIDINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER;

ARTICLE; BICARBONATE BLOOD LEVEL; BREAST FEEDING; CLINICAL ASSESSMENT; COLIC; COLONY FORMING UNIT; CONTROLLED STUDY; CRYING; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNE RESPONSE; INFANT; KLEBSIELLA; LACTOBACILLUS REUTERI; MAJOR CLINICAL STUDY; MICROBIAL COMMUNITY; MICROBIOME; NEUTROPHIL COUNT; PLACEBO EFFECT; PRIORITY JOURNAL; PROTEUS; RANDOMIZED CONTROLLED TRIAL; TIME TO TREATMENT; UNSPECIFIED SIDE EFFECT; VEILLONELLA; FEMALE; FOLLOW UP; MALE; METABOLISM; NEWBORN; TREATMENT OUTCOME;

BIOMARKERS; COLIC; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LACTOBACILLUS REUTERI; MALE; PROBIOTICS; TREATMENT OUTCOME;

EID: 85030450337     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2017.07.036     Document Type: Article

References (42)

1. Wessel, M.A., Cobb, J.C., Jackson, E.B., Harris, G.S. Jr, Detwiler, A.C., Paroxysmal fussing in infancy, sometimes called colic. Pediatrics 14 (1954), 421–435.
2. Barr, R.G., Rotman, A., Yaremko, J., Leduc, D., Francoeur, T.E., The crying of infants with colic: a controlled empirical description. Pediatrics 90 (1992), 14–21.
3. Chau, K., Lau, E., Greenberg, S., Jacobson, S., Yazdani-Brojeni, P., Verma, N., et al. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr 166 (2015), 74–78.
4. Harb, T., Matsuyama, M., David, M., Hill, R.J., Infant colic-what works: a systematic review of interventions for breast-fed infants. J Pediatr Gastroenterol Nutr 62 (2016), 668–686.
5. Savino, F., Cordisco, L., Tarasco, V., Calabrese, R., Palumeri, E., Matteuzzi, D., Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr 98 (2009), 1582–1588.
6. Rhoads, J.M., Fatheree, N.Y., Norori, J., Liu, Y., Lucke, J.F., Tyson, J.E., et al. Altered fecal microflora and increased fecal calprotectin in infants with colic. J Pediatr 155 (2009), 823–828.
7. Liu, Y., Fatheree, N.Y., Dingle, B.M., Tran, D.Q., Rhoads, M., Lactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis. PLoS ONE, 8, 2013, e56547.
8. Liu, Y., Fatheree, N.Y., Mangalat, N., Rhoads, J.M., Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 299 (2010), G1087–96.
9. Liu, Y., Tran, D.Q., Fatheree, N.Y., Marc, R.J., Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 307 (2014), G177–86.
10. Barr, R.G., Kramer, M.S., Boisjoly, C., McVey-White, L., Pless, I.B., Parental diary of infant cry and fuss behaviour. Arch Dis Child 63 (1988), 380–387.
11. Physician LINK, Memorial hermann laboratory directory of services. https://secure1.mhhs.org/clinicalreference/LabTest/LabTestIndex.asp, 2016 Accessed September 22, 2017.
12. U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS, Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0. Novermber http://rsc.tech-res.com/docs/default-source/safety/daids_ae_grading_table_v2_nov2014.pdf, 2014 Accessed September 22, 2017.
13. Harris, P.A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., Conde, J.G, Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42 (2009), 377–381.
14. Mangalat, N., Liu, Y., Fatheree, N.Y., Ferris, M.J., Van Arsdall, M.R., Chen, Z., et al. Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial. PLoS ONE, 7, 2012, e43910.
15. Gupta, R.W., Tran, L., Norori, J., Ferris, M.J., Eren, A.M., Taylor, C.M., et al. Histamine-2 receptor blockers alter the fecal microbiota in premature infants. J Pediatr Gastroenterol Nutr 56 (2013), 397–400.
16. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7 (2010), 335–336.
17. The R Foundation, The R Project for Statistical Computing. http://www.r-project.org/, 2016 Accessed September 22, 2017.
18. Ozyurek, E., Cetintas, S., Ceylan, T., Ogus, E., Haberal, A., Gurakan, B., et al. Complete blood count parameters for healthy, small-for-gestational-age, full-term newborns. Clin Lab Haematol 28 (2006), 97–104.
19. Segel, G.B., Halterman, J.S., Neutropenia in pediatric practice. Pediatr Rev 29 (2008), 12–23.
20. Li, F., Ma, J., Geng, S., Wang, J., Ren, F., Sheng, X., Comparison of the different kinds of feeding on the level of fecal calprotectin. Early Hum Dev 90 (2014), 471–475.
21. Savino, F., Castagno, E., Calabrese, R., Viola, S., Oggero, R., Miniero, R., High faecal calprotectin levels in healthy, exclusively breast-fed infants. Neonatology 97 (2010), 299–304.
22. Konikoff, M.R., Denson, L.A., Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006), 524–534.
23. Boyle, R.J., Robins-Browne, R.M., Tang, M.L., Probiotic use in clinical practice: what are the risks?. Am J Clin Nutr 83 (2006), 1256–1264.
24. Hammerman, C., Bin-Nun, A., Kaplan, M., Safety of probiotics: comparison of two popular strains. BMJ 333 (2006), 1006–1008.
25. Centers for Disease Control and Prevention., Emergency Preparedness and Response. Fatal gastrointestinal mucormycosis in an infant following ingestion of contaminated dietary supplement-Connecticut, 2014 https://emergency.cdc.gov/HAN/han00373.asp, 2014 Accessed September 22, 2017.
26. Wang, Q., Dong, J., Zhu, Y., Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 47 (2012), 241–248.
27. Xu, M., Wang, J., Wang, N., Sun, F., Wang, L., Liu, X.H., The efficacy and safety of the probiotic bacterium Lactobacillus reuteri DSM 17938 for infantile colic: a meta-analysis of randomized controlled trials. PLoS ONE, 10, 2015, e0141445.
28. Dale, D.C., How I manage children with neutropenia. Br J Haematol 178 (2017), 351–363.
29. Chiarello, P., Magnolia, M., Rubino, M., Liguori, S.A., Miniero, R., Thrombocytosis in children. Minerva Pediatr 63 (2011), 507–513.
30. Siddiqui, I., Majid, H., Abid, S., Update on clinical and research application of fecal biomarkers for gastrointestinal diseases. World J Gastrointest Pharmacol Ther 8 (2017), 39–46.
31. Fatheree, N.Y., Liu, Y., Ferris, M., Van, A.M., McMurtry, V., Zozaya, M., et al. Hypoallergenic formula with Lactobacillus rhamnosus GG for babies with colic: a pilot study of recruitment, retention, and fecal biomarkers. World J Gastrointest Pathophysiol 7 (2016), 160–170.
32. Partty, A., Kalliomaki, M., Salminen, S., Isolauri, E., Infantile colic is associated with low-grade systemic inflammation. J Pediatr Gastroenterol Nutr 64 (2017), 691–695.
33. Akimova, T., Beier, U.H., Wang, L., Levine, M.H., Hancock, W.W., Helios expression is a marker of T cell activation and proliferation. PLoS ONE, 6, 2011, e24226.
34. Thornton, A.M., Korty, P.E., Tran, D.Q., Wohlfert, E.A., Murray, P.E., Belkaid, Y., et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184 (2010), 3433–3441.
35. Moore, D.J., Robb, T.A., Davidson, G.P., Breath hydrogen response to milk containing lactose in colicky and noncolicky infants. J Pediatr 113 (1988), 979–984.
36. Savino, F., Cresi, F., Pautasso, S., Palumeri, E., Tullio, V., Roana, J., et al. Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr 93 (2004), 825–829.
37. Savino, F., Bailo, E., Oggero, R., Tullio, V., Roana, J., Carlone, N., et al. Bacterial counts of intestinal Lactobacillus species in infants with colic. Pediatr Allergy Immunol 16 (2005), 72–75.
38. Roos, S., Dicksved, J., Tarasco, V., Locatelli, E., Ricceri, F., Grandin, U., et al. 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS ONE, 8, 2013, e56710.
39. Sung, V., Hiscock, H., Tang, M.L., Mensah, F.K., Nation, M.L., Satzke, C., et al. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ, 348, 2014, g2107.
40. Mi, G.L., Zhao, L., Qiao, D.D., Kang, W.Q., Tang, M.Q., Xu, J.K., Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie Van Leeuwenhoek 107 (2015), 1547–1553.
41. Szajewska, H., Gyrczuk, E., Horvath, A., Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 162 (2013), 257–262.
42. Savino, F., Cordisco, L., Tarasco, V., Palumeri, E., Calabrese, R., Oggero, R., et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126 (2010), e526–33.